Murali Ramachandra

1PUBLICATIONS
0CO-AUTHORS
Pharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Jun 09, 2021
PD-1 derived CA-170 is an oral immune checkpoint inhibitor that exhibits preclinical anti-tumor efficacy.

Pottayil G Sasikumar, Naremaddepalli S Sudarshan, Srinivas Adurthi

Pageof 1

Frequent Collaborators